Amides useful as inhibitors of voltagegated sodium channels

Details for Australian Patent Application No. 2008310661 (hide)

Owner Vertex Pharmaceuticals Incorporated

Inventors Termin, Andreas; Chen, Weichuan Caroline; Wilson, Dean; Krenitsky, Paul

Agent Baldwins

Pub. Number AU-A-2008310661

PCT Pub. Number WO2009/049181

Priority 60/979,292 11.10.07 US

Filing date 10 October 2008

Wipo publication date 16 April 2009

International Classifications

C07D 213/72 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/33 (2006.01) - Heterocyclic compounds

A61P 19/02 (2006.01) Drugs for skeletal disorders

Event Publications

29 April 2010 PCT application entered the National Phase

  PCT publication WO2009/049181 Priority application(s): WO2009/049181

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008310663-Aryl amides useful as inhibitors of voltage-gated sodium channels

2008310660-Heteroaryl amides useful as inhibitors of voltage-gated sodium channels